ARCHIVES

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

RFA Announced On Model For Planning community Prevention Program

October 20, 1978

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Cancer Program Advocates, Success Overcame Powerful Negative Factors To Win Budget Fight

August 10, 1979